MAGE-C1 (CT7) gene expression in multiple myeloma: Relationship to sperm protein 17 [3]

European Journal of Haematology

Volumn 67, Issue 5-6, 2001, Pages 332-334

  Lim, Seah H ^a,b   Bumm, Klaus ^a   Chiriva Intemati, Maurizio ^a   Xue, Yuying ^a   Wang, Zhiqing ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Harrington Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; SPERM PROTEIN 17; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LETTER; MAGE C1 GENE; MULTIGENE FAMILY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CANCER VACCINES; CARRIER PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIPLE MYELOMA; NEOPLASM PROTEINS;

EID: 0035712310     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2001.00552.x     Document Type: Letter

References (5)

1. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma
2. Sperm protein 17 (Sp17) in multiple myeloma: Opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus host disease risk
3. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
4. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
5. Genes encoding turnor-specific antigens are expressed in human myeloma cells